PCDH9 and esophageal squamous cell carcinoma: The results revealed a significant correlation between PCDH9-AS1 expression and the clinical staging of ESCC patients, while no correlation was observed with gender, age, pathological grading, lymph node metastasis, or tumor staging (Table 2).